Jamie Christensen - Dec 16, 2021 Form 4 Insider Report for Mirati Therapeutics, Inc. (MRTX)

Role
EVP, Chief Scientific Officer
Signature
/s/ Vickie Reed, Attorney-in-Fact
Stock symbol
MRTX
Transactions as of
Dec 16, 2021
Transactions value $
$0
Form type
4
Date filed
12/17/2021, 06:10 PM
Previous filing
Dec 7, 2021
Next filing
Jan 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Award $0 +19.1K +32.13% $0.00 78.7K Dec 16, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of Performance Stock Units ("PSUs"). 25% of the PSUs will vest on December 16, 2022, the one-year anniversary of the Achievement Date, and then 25% annually for the next 3 years, subject to Dr. Christensen's continuous service.
F2 Includes 88 shares acquired under the ESPP Purchase on 11/30/2021